Le Lézard
Classified in: Health, Business
Subjects: NPT, LIC

Herzing University and Medical College of Wisconsin Forge Strategic Partnership to Launch Innovative 4+1 Program


Collaborative new partnership to deliver much-needed career pathways for future public health professionals and address industry-wide talent shortages

MILWAUKEE, March 13, 2024 /PRNewswire/ -- Herzing University and the Medical College of Wisconsin (MCW) are excited to announce a pioneering collaboration aimed at providing students with a streamlined route to obtain both undergraduate and graduate degrees in five years. The newly established 4+1 Program integrates Herzing University's Bachelor of Science in Health Sciences (BSHS) curriculum with MCW's renowned Master of Public Health (MPH) Program, offering direct admission to qualified BSHS students.

The 4+1 Program represents a significant step in our efforts to cultivate the next generation of public health leaders.

The 4+1 Program is a five-year dual degree initiative designed to facilitate seamless transition for eligible Herzing University students into the Master of Public Health Program at MCW's School of Graduate Studies. This partnership will enable students to leverage their academic foundation toward earning a Master of Public Health degree while fulfilling the requirements for their bachelor's degree.

"At Herzing University, we're committed to providing innovative pathways for our students to excel in the ever-evolving healthcare landscape," said Dr. Sarah Olson, PhD, Program Chair ? Healthcare Management/Healthcare Administration & Health Sciences, Herzing University. "Our partnership with the Medical College of Wisconsin opens doors to unparalleled opportunities for our students, allowing them to become leaders in public health and make a meaningful impact on community well-being."

Key features of the 4+1 Program include:

The inaugural cohort of the 4+1 Program is set to commence in May 2024, marking the beginning of an exciting educational journey for aspiring public health and healthcare professionals.

"The Medical College of Wisconsin is excited to partner with Herzing University in launching the 4+1 Program, which represents a significant step forward in our joint efforts to cultivate the next generation of public health leaders," said Kim Contardi, MPH, MPH Program Manager, Medical College of Wisconsin. "By integrating our expertise and commitment to student success, we're creating a dynamic educational pathway that prepares graduates to address complex health challenges and foster innovative connections with communities and healthcare systems."

Program participants will be able to access:

The collaboration between Herzing University and the Medical College of Wisconsin represents a significant step forward in advancing healthcare education and preparing future leaders in public health. Through the 4+1 Program, students will receive unparalleled opportunities to enhance their academic and professional growth, ultimately contributing to the betterment of healthcare systems and communities.

For more information, please visit the Herzing University and Medical College of Wisconsin websites.

About Herzing University

Herzing University is an accredited, private nonprofit institution with 11 campuses across eight states and an online division. Founded in 1965 and headquartered in the heart of Milwaukee, more than 40,000 students have graduated from the University's career-focused and flexible master's, bachelor's, and associate degree, and diploma programs. Fields of study include nursing and a Doctor of Nursing Practice (DNP) program through Herzing's School of Nursing, as well as programs across healthcare, technology, business, and public safety. Since 2013, U.S. News & World Report has recognized Herzing University annually for having some of the nation's top online programs. Herzing University is accredited by the Higher Learning Commission. More information about Herzing University is available at www.herzing.edu.

About the Medical College of Wisconsin

With a history dating back to 1893, The Medical College of Wisconsin is dedicated to leadership and excellence in education, patient care, research, and community engagement. More than 1,400 students are enrolled in MCW's medical school and graduate school programs in Milwaukee, Green Bay, and Central Wisconsin. MCW's School of Pharmacy opened in 2017. A major national research center, MCW is the largest research institution in the Milwaukee metro area and second largest in Wisconsin. In the last 10 years, faculty received more than $1.5 billion in external support for research, teaching, training, and related purposes. This total includes highly competitive research and training awards from the National Institutes of Health (NIH). Annually, MCW faculty direct or collaborate on more than 3,100 research studies, including clinical trials. Additionally, more than 1,600 physicians provide care in virtually every specialty of medicine for more than 2.8 million patients annually.

Contact:
Brett Gerrish
517-899-7795
[email protected]

SOURCE Herzing University


These press releases may also interest you

at 08:20
Merck , known as MSD outside of the United States and Canada, and Orion Corporation ("Orion") today announced that notice has been provided of the mutual exercise of an option to convert the companies' ongoing co-development and co-commercialization...

at 08:20
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages against Exact Sciences on June 28, 2024, in federal court in the...

at 08:15
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...

at 08:15
The 4th of July is almost here. While we look forward to the parties, BBQ's, and fireworks, many of our pets dread this time of year. Fireworks, with their bright flashes and loud booms, frighten many pets. Sadly, many scared pets escape and get lost...

at 08:10
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited...



News published on and distributed by: